These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12596751)

  • 41. RAS inhibition in hypertension.
    Ibrahim MM
    J Hum Hypertens; 2006 Feb; 20(2):101-8. PubMed ID: 16397519
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the primary prevention of myocardial infarction in hypertensive patients.
    Baer JT; Sauer WH; Berlin JA; Kimmel SE
    Am J Cardiol; 2004 Aug; 94(4):479-81. PubMed ID: 15325933
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists.
    Quan A
    Early Hum Dev; 2006 Jan; 82(1):23-8. PubMed ID: 16427219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical practice. Nondiabetic kidney disease.
    Levey AS
    N Engl J Med; 2002 Nov; 347(19):1505-11. PubMed ID: 12421894
    [No Abstract]   [Full Text] [Related]  

  • 47. Optimal care of lupus nephritis patients.
    Jadoul M
    Lupus; 2005; 14(1):72-6. PubMed ID: 15732292
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Chronic kidney disease: do aldosterone antagonists help?].
    Rump LC
    Dtsch Med Wochenschr; 2014 Nov; 139(45):2274. PubMed ID: 25350238
    [No Abstract]   [Full Text] [Related]  

  • 49. Editorial comment.
    El Nahas M
    Nephron Clin Pract; 2009; 113(4):c293. PubMed ID: 19950440
    [No Abstract]   [Full Text] [Related]  

  • 50. ACE inhibition: antihypertensive treatment of choice in progressive chronic renal failure?
    Aurell M
    Nephrol Dial Transplant; 1993; 8(8):680-1. PubMed ID: 8414150
    [No Abstract]   [Full Text] [Related]  

  • 51. Associated effect of hepatic hydroxymethylglutaryl coenzyme A reductase + angiotensin converting enzyme inhibitors on the progression of renal failure in hypertensive subjects.
    Scanferla F; Toffoletto PP; Roncali D; Bazzato G
    Am J Hypertens; 1991 Oct; 4(10 Pt 1):868. PubMed ID: 1747221
    [No Abstract]   [Full Text] [Related]  

  • 52. Proteinuria in chronic kidney disease in cats--prognostic marker or therapeutic target?
    Elliott J; Syme HM
    J Vet Intern Med; 2006; 20(5):1052-3. PubMed ID: 17063695
    [No Abstract]   [Full Text] [Related]  

  • 53. Progression of chronic renal failure.
    Traindl O; Pohanka E; Kovarik J
    Lancet; 1988 Oct; 2(8617):962-3. PubMed ID: 2902407
    [No Abstract]   [Full Text] [Related]  

  • 54. Lipids and the kidney.
    Keane WF
    Kidney Int; 1994 Sep; 46(3):910-20. PubMed ID: 7996813
    [No Abstract]   [Full Text] [Related]  

  • 55. Therapeutic concepts of proteinuria and intra-glomerular hypertension.
    Woo KT
    Singapore Med J; 1998 Jun; 39(6):271-2. PubMed ID: 9803817
    [No Abstract]   [Full Text] [Related]  

  • 56. The epidemiology of chronic kidney disease stages 1 to 4 and cardiovascular disease: a high-risk combination.
    Menon V; Sarnak MJ
    Am J Kidney Dis; 2005 Jan; 45(1):223-32. PubMed ID: 15696466
    [No Abstract]   [Full Text] [Related]  

  • 57. Angiotensin-converting enzyme inhibitors: therapeutic implications in the management of chronic renal failure.
    el Nahas AM
    Contrib Nephrol; 1990; 81():240-7. PubMed ID: 2093503
    [No Abstract]   [Full Text] [Related]  

  • 58. [Chemotherapy to arrest the progression of chronic kidney failure].
    Sanaka T
    Nihon Naika Gakkai Zasshi; 2000 Jul; 89(7):1304-11. PubMed ID: 11032495
    [No Abstract]   [Full Text] [Related]  

  • 59. Angiotensin-converting enzyme inhibitors and progression of renal disease: evidence from clinical studies.
    Wenzel UO
    Contrib Nephrol; 2001; (135):200-11. PubMed ID: 11705285
    [No Abstract]   [Full Text] [Related]  

  • 60. Therapy of systemic hypertension in chronic renal failure.
    Maschio G; Oldrizzi L; Rugiu C
    Contrib Nephrol; 1992; 98():112-5. PubMed ID: 1493722
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.